Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × HER2-positive Breast Cancer × pegfilgrastim × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 21 Lymphoma 19 Neutropenia 13 Lymphoma, Large B-Cell, Diffuse 12 Neoplasms 10 Lymphoma, Non-Hodgkin 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Leukemia 7 Carcinoma, Non-Small-Cell Lung 7 Lymphoma, Follicular 6 Burkitt Lymphoma 6 Leukemia, Lymphocytic, Chronic, B-Cell 5 Sarcoma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, B-Cell, Marginal Zone 4 Lung Neoplasms 4 Hodgkin Disease 4 Urinary Bladder Neoplasms 3 Rhabdomyosarcoma 3 Ovarian Neoplasms 3 Chemotherapy-induced Neutropenia 3 Waldenstrom Macroglobulinemia 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Leukemia, Myeloid, Acute 2

Interventions

Trastuzumab 11 pyrotinib 8 pertuzumab 5 Docetaxel 5 Paclitaxel 2 Carboplatin 2 Capecitabine 2 tucatinib 1 trastuzumab deruxtecan 1 pegfilgrastim 1 neratinib 1 liposomal doxorubicin 1 inavolisib 1 exemestane 1 envafolimab 1 dalpiciclib 1 atezolizumab 1 Neoadjuvant Therapy 1 Metformin 1 Leuprolide 1 Goserelin 1 Fulvestrant 1 Drug Therapy 1 Anastrozole 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03571633 2025-11-26

BREASTIMMU02

Centre Leon Berard

Phase 2 Active not recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡